Related Experiment Videos
Congenital central alveolar hypoventilation syndrome in six infants
Insights
Congenital alveolar hypoventilation syndrome (CCHS) in infants often requires mechanical ventilation. Survivors face significant challenges, including behavioral control of breathing and frequent rehospitalizations.
Area of Science:
- Pediatric Pulmonology
- Neonatology
- Neuroscience
Background:
- Congenital Alveolar Hypoventilation Syndrome (CCHS) is a rare disorder affecting autonomic nervous system function.
- CCHS necessitates mechanical ventilation for survival in affected infants.
- Investigating CCHS pathophysiology is crucial for improving patient outcomes.
Observation:
- Six infants with CCHS were monitored over several years, with two cases associated with Hirchsprung's disease.
- All infants required tracheostomy and mechanical ventilation; three survived, including one with CCHS and Hirchsprung's disease.
- Survivors experienced frequent rehospitalizations and behavioral control issues with ventilation, particularly during sleep.
Findings:
- One infant with CCHS experienced severe symptoms after the onset of delta sleep, a critical developmental stage.
- Long-term survival in CCHS presents challenges, including the development of "behavioral control" issues related to ventilation.
- The study suggests a potential defect in chemoreceptor information integration rather than a primary central chemoreceptor defect in CCHS.
Implications:
- Early identification and management of CCHS are vital for improving infant survival rates.
- Understanding the neurobiological underpinnings of CCHS can lead to targeted therapeutic strategies.
- Further research into autonomic nervous system integration in CCHS may reveal new treatment avenues.
Abstract:
Six infants with congenital alveolar hypoventilation syndrome (CCHS) were seen and observed over several years. Two had an association of CCHS with Hirchsprung's disease. All infants were treated by tracheostomy and mechanical ventilation. Three infants have survived (including one with CCHS and Hirchsprung's disease). However, all survivors have required frequent rehospitalization. The infant with the longest survival (now 4 years of age) has developed significant daytime problems involving the "behavioral control" of ventilation. One infant was considered as a "near miss for sudden infant death syndrome" and became significantly symptomatic after establishment of delta (stage 3-4 non-rapid eye movement) sleep, which normally develops between 2 and 4 months of age. CCHS involves autonomic nervous system dysfunction, and the question of a defect involving the integration of chemoreceptor information more than a direct defect of the central chemoreceptor is discussed.